Running Stocks: The Empire District Electric Company (NYSE:EDE), Wheeler Real Estate Investment Trust (NASDAQ:WHLR), QLT (NASDAQ:QLTI), Genesis Healthcare (NYSE:GEN)

USD Partners LP (NYSE:USDP) shares moved down -6.96% in last trading session and ended the day at $6.82. USDP Gross Margin is 48.20% and its has a return on assets of 6.70%. USD Partners LP (NYSE:USDP) quarterly performance is -27.45%.

USD Partners LP (NYSE: USDP) announced that the Board of Directors of its general partner declared a quarterly cash distribution of $0.30 per unit for the fourth quarter of 2015 ($1.20 per unit on an annualized basis), representing an increase of $0.0075 per unit or 2.6% over the prior quarter. The distribution is payable on February 19, 2016, to unitholders of record as of the close of business on February 15, 2016.

The Empire District Electric Company (NYSE:EDE) ended the last trading day at $28.20. Company weekly volatility is calculated as 4.23% and price to cash ratio as 649.94. The Empire District Electric Company (NYSE:EDE) showed a weekly performance of -5.31%.

At the Board of Directors meeting of The Empire District Electric Company (NYSE:EDE) held today, the Directors declared a quarterly dividend of $0.26 per share. The dividend is payable March 15, 2016, to holders of record as of March 1, 2016.

On 09 February, Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares fell -8.09% and was closed at $1.25. Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) year to date (YTD) performance is -35.23%.

Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) announced that its Board of Directors has authorized a $0.0175 per share monthly cash dividend for shareholders of record of the Company’s common stock on January 31, 2016, to be paid on or about February 29, 2016.

QLT Inc. (NASDAQ:QLTI) shares fell -4.47% in last trading session and ended the day at $2.35. QLTI has a return on assets of -2.20%. QLT Inc. (NASDAQ:QLTI) quarterly performance is -16.67%.

QLT Inc. (NASDAQ:QLTI) announces that it has acquired 7,200,000 common shares (the “Aralez Shares”) of Aralez Pharmaceuticals Inc. (“Aralez”) for a per share price of US$6.25 and an aggregate purchase price of US$45 million. Aralez is a newly formed global specialty pharmaceutical company resulting from the business combination of POZEN Inc. and Tribute Pharmaceuticals Canada Inc. which completed today. Commencing on or about February 8, 2016, the common shares of Aralez will trade on NASDAQ under the ticker symbol “ARLZ”, and on or about February 10, 2016, will trade on the Toronto Stock Exchange under the ticker symbol “ARZ”.

Genesis Healthcare, Inc. (NYSE:GEN) caters to the Healthcare space. It has a net profit margin of -3.70% and weekly performance is -16.76%. On the last day of trading company shares ended up at $1.49. Genesis Healthcare, Inc. (NYSE:GEN) distance from 50-day simple moving average (SMA50) is -56.02%.

UBS Securities decreased the shares of Genesis Healthcare Inc (NYSE:GEN) from a Neutral rating to Sell rating in a research note issued to clients and investors on Monday, 8 February. The firm after the upgrade has $1.50 target price per share on firm.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *